Tarsus Pharmaceuticals, Inc. (TARS)
Tarsus Pharmaceuticals, Inc. (TARS) Insider Trading
Directors, officers and holders of more than 10% of TARS report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 250 transactions on file: 0 with code P, 20 with code S and 30 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | LINK WILLIAM J PHD | Director | M Exercise | 201 | Not measured | Not measured |
| Sep 15, 2026 | PYOTT DAVID E I | Director | M Exercise | 201 | Not measured | Not measured |
| Sep 15, 2026 | LINK WILLIAM J PHD | Director | S Sale | 759 | $79.00 | $59,961 |
| Sep 15, 2026 | LINK WILLIAM J PHD | Director | S Sale | 66 | $80.01 | $5,281 |
| Sep 15, 2026 | YARNO WENDY L | Director | M Exercise | 302 | Not measured | Not measured |
| Sep 15, 2026 | LINK WILLIAM J PHD | Director | S Sale | 11,675 | $78.33 | $914,503 |
| Sep 15, 2026 | YARNO WENDY L | Director | M Exercise | 302 | Not measured | Not measured |
| Sep 15, 2026 | LINK WILLIAM J PHD | Director | M Exercise | 201 | Not measured | Not measured |
| Sep 15, 2026 | PYOTT DAVID E I | Director | M Exercise | 201 | Not measured | Not measured |
| Sep 4, 2026 | Lin Elizabeth Yeu | Chief Medical Officer | S Sale | 5,386 | $90.00 | $484,740 |
| Sep 4, 2026 | Lin Elizabeth Yeu | Chief Medical Officer | S Sale | 1,590 | $85.00 | $135,150 |
| Sep 4, 2026 | Neervannan Seshadri | Chief Operating Officer | S Sale | 4,564 | $85.00 | $387,940 |
| Sep 4, 2026 | Azamian Bobak R. | President/CEO and Board Chair | S Sale | 7,100 | $90.27 | $640,917 |
| Sep 4, 2026 | Lin Elizabeth Yeu | Chief Medical Officer | S Sale | 1,590 | $90.00 | $143,100 |
| Sep 4, 2026 | Azamian Bobak R. | President/CEO and Board Chair | S Sale | 2,900 | $91.27 | $264,683 |
| Sep 4, 2026 | Lin Elizabeth Yeu | Chief Medical Officer | S Sale | 5,387 | $85.00 | $457,895 |
| Sep 2, 2026 | Azamian Bobak R. | President/CEO and Board Chair | S Sale | 10,000 | $80.06 | $800,600 |
| Sep 2, 2026 | Lin Elizabeth Yeu | Chief Medical Officer | S Sale | 5,387 | $80.00 | $430,960 |
| Sep 2, 2026 | Lin Elizabeth Yeu | Chief Medical Officer | S Sale | 1,590 | $80.00 | $127,200 |
| Sep 1, 2026 | Lin Elizabeth Yeu | Chief Medical Officer | S Sale | 4,601 | $73.86 | $339,830 |
| Jun 25, 2026 | Goldberg Andrew D. | Director | A Award | 2,417 | Not measured | Not measured |
| Jun 25, 2026 | PYOTT DAVID E I | Director | A Award | 806 | Not measured | Not measured |
| Jun 25, 2026 | PYOTT DAVID E I | Director | A Award | 3,837 | Not measured | Not measured |
| Jun 25, 2026 | Goldberg Andrew D. | Director | A Award | 3,837 | Not measured | Not measured |
| Jun 25, 2026 | PYOTT DAVID E I | Director | A Award | 2,417 | Not measured | Not measured |
| Jun 25, 2026 | LINK WILLIAM J PHD | Director | A Award | 3,837 | Not measured | Not measured |
| Jun 25, 2026 | LINK WILLIAM J PHD | Director | A Award | 806 | Not measured | Not measured |
| Jun 25, 2026 | Morrison Scott W | Director | A Award | 3,837 | Not measured | Not measured |
| Jun 25, 2026 | Goodrich Katherine | Director | A Award | 3,837 | Not measured | Not measured |
| Jun 25, 2026 | YARNO WENDY L | Director | A Award | 2,417 | Not measured | Not measured |
| Jun 25, 2026 | Goodrich Katherine | Director | A Award | 2,417 | Not measured | Not measured |
| Jun 25, 2026 | YARNO WENDY L | Director | A Award | 1,209 | Not measured | Not measured |
| Jun 25, 2026 | Morrison Scott W | Director | A Award | 2,417 | Not measured | Not measured |
| Jun 25, 2026 | YARNO WENDY L | Director | A Award | 3,837 | Not measured | Not measured |
| Jun 25, 2026 | LINK WILLIAM J PHD | Director | A Award | 2,417 | Not measured | Not measured |
| Jun 25, 2026 | CHAUDHURI BHASKAR | Director | A Award | 2,417 | Not measured | Not measured |
| Jun 25, 2026 | CHAUDHURI BHASKAR | Director | A Award | 3,837 | Not measured | Not measured |
| Jun 17, 2026 | Azamian Bobak R. | President/CEO and Board Chair | S Sale | 5,418 | $61.81 | $334,887 |
| Jun 17, 2026 | Azamian Bobak R. | President/CEO and Board Chair | S Sale | 4,582 | $61.24 | $280,602 |
| Jun 16, 2026 | Farrow Jeffrey S | See Remarks | S Sale | 14,396 | $60.95 | $877,436 |
| Jun 15, 2026 | Farrow Jeffrey S | See Remarks | M Exercise | 27,881 | Not measured | Not measured |
| Jun 15, 2026 | Goodrich Katherine | Director | S Sale | 2,954 | $62.08 | $183,384 |
| Jun 15, 2026 | LINK WILLIAM J PHD | Director | S Sale | 1,928 | $62.94 | $121,348 |
| Jun 15, 2026 | LINK WILLIAM J PHD | Director | S Sale | 10,572 | $61.97 | $655,147 |
| Jun 15, 2026 | Farrow Jeffrey S | See Remarks | M Exercise | 27,881 | Not measured | Not measured |
| Jun 12, 2026 | Goodrich Katherine | Director | M Exercise | 2,954 | Not measured | Not measured |
| Jun 12, 2026 | LINK WILLIAM J PHD | Director | M Exercise | 2,954 | Not measured | Not measured |
| Jun 12, 2026 | Goldberg Andrew D. | Director | M Exercise | 2,954 | Not measured | Not measured |
| Jun 12, 2026 | YARNO WENDY L | Director | M Exercise | 2,954 | Not measured | Not measured |
| Jun 12, 2026 | CHAUDHURI BHASKAR | Director | M Exercise | 2,954 | Not measured | Not measured |
The full Form 4 history is on the TARS company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.